Differential effects of the new glucocorticoid receptor antagonist ORG 34517 and RU486 (mifepristone) on glucocorticoid receptor nuclear translocation in the AtT20 cell line

Annals of the New York Academy of Sciences

Volumn 1148, Issue , 2008, Pages 536-541

  Peeters, B W M M ^a   Ruigt, G S F ^a   Craighead, M ^b   Kitchener, P ^c  

^a NV ORGANON   (Netherlands)

^b MERCK RESEARCH LABORATORIES   (United States)

^c FLUOFARMA   (France)

Author keywords

AtT20 cell line; Competitive antagonist; Corticosterone; Glucocorticoid receptor; Nuclear receptor translocation; ORG 34517; RU486

Indexed keywords

11BETA (1,3 BENZODIOXOL 5 YL) 17BETA HYDROXY 17ALPHA (1 PROPYNYL)ESTRA 4,9 DIEN 3 ONE; CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; MIFEPRISTONE; PARTIAL AGONIST; RTI 3021 012; RTI 3021 022; UNCLASSIFIED DRUG;

ANIMAL CELL; CELL NUCLEUS; CONFERENCE PAPER; CONTROLLED STUDY; CYTOPLASM; DRUG RECEPTOR BINDING; GENE TARGETING; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL;

EID: 57649210173     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1410.072     Document Type: Conference Paper

References (18)

1. Karin, M. 1998. New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell 93 : 487 490.
2. Rupprecht, R., J.M.H.M. Reul, B. van Steensel, et al. 1993. Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. Eur. J. Pharmacol. 247 : 145 154.
3. Czar, M.J., R.H. Lyons, M.J. Welsh, et al. 1995. Evidence that the FK506-binding immunophilin heat shock protein 56 is required for tracking of the glucocorticoid receptor from the cytoplasm to the nucleus. Mol. Endocrinol. 9 : 1549 1560.
4. Qi, M., L.J. Stasenko & D.B. DeFranco. 1990. Recycling and desensitization of glucocorticoid receptors in v-mos transformed cells depend on the ability of nuclear receptors to modulate gene expression. Mol. Endocrinol. 4 : 455 464.
5. Jewell, C.M., J.C. Webster, K.L. Burnstein, et al. 1995. Immunocytochemical analysis of hormone mediated nuclear translocation of wild type and mutant glucocorticoid receptors. J. Steroid Biochem. Mol. Biol. 55 : 135 146.
6. Pariante, C.M., B.D. Pearce, T.L. Pisell, et al. 2001. The steroid receptor antagonists RU40555 and RU486 activate glucocorticoid receptor translocation and are not excreted by the steroid hormones transporter in L929 cells. J. Endocrinol. 169 : 309 320.
7. Nordeen, S.K., B.J. Bona, C.A. Beck, et al. 1995. The two faces of a steroid antagonist: when an antagonist isn't. Steroids 60 : 97 104.
8. Fryer, C.J., H.K. Kinyamu, I. Rogatsky, et al. 2000. Selective activation of the glucocorticoid receptor by steroid antagonists in human breast cancer and osteosarcoma cells. J. Biol. Chem. 275 : 17771 17777.
9. Distelhorst, C.W. & K.J. Howard. 1990. Evidence from pulse-chase labeling studies that the antiglucocorticoid hormone RU486 stabilizes the nonactivated form of the glucocorticoid receptor in mouse lymphoma cells. J. Steroid Biochem. 36 : 25 31.
10. Beck, C.A., P.A. Estes, B.J. Bona, et al. 1993. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors. Endocrinology 133 : 728 740.
11. Bourgeois, S., M. Pfahl & E.-E. Baulieu. 1984. DNA binding properties of glucocorticosteroid receptors bound to the steroid antagonist RU-486. EMBO J. 3 : 751 755.
12. Yu, C., N. Warriar & M.V. Govindan. 1995. Cysteines 638 and 665 in the hormone binding domain of human glucocorticoid receptor define the specificity to glucocorticoids. Biochemistry 34 : 14163 14173.
13. Wagner, B.L., G. Pollio, P. Giangrande, et al. 1999. The novel progesterone receptor antagonists RTI 3021-012 and RTI 3021-022 exhibit complex glucocorticoid receptor antagonist activities: implications for the development of dissociated antiprogestins. Endocrinology 140 : 1449 1458.
14. Sackey, F.N.A., R.J.G. Hache, T. Reich, et al. 1996. Determinants of subcellular distribution of the glucocorticoid receptor. Mol. Endocrinol. 10 : 1191 1205.
15. Gruol, D.J. & J. Altschmied. 1993. Synergistic induction of apoptosis with glucocorticoids and 3′,5'cyclic adenosine monophosphate reveals agonistic activity by RU486. Mol. Endocrinol. 7 : 104 113.
16. Sheppard, K.E. 1995. Cyclosporin A and FK506 are potent activators of proopiomelanocortin-derived peptide secretion without affecting corticotrope glucocorticoid receptor function. J. Neuroendocrinol. 7 : 833 890.
17. Peeters, B.W.M.M., J.A.D.M. Tonnaer, M.B. Groen, et al. 2004. Glucocorticoid receptor antagonists: new tools to investigate disorders characterized by cortisol hypersecretion. Stress 7 : 233 241.
18. Sarkar, N.N. 2002. Mifepristone: bioavailability, pharmacokinetics and use-effectiveness. Eur. J. Obstet. Gynecol. Reprod. Biol. 101 : 113 120.